Explain this page
Arphra AIPlain-English read on Thermo Fisher Scientific Inc.’s valuationNo recent stories.
today
- Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle35d
- Thermo Fisher Scientific's Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials40d
- International Markets and Thermo Fisher (TMO): A Deep Dive for Investors42d
- Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing42d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$473.10
+0.34% vs spot
Recommendation
Hold
18 of 19 methods
Method spread
4bull13bear
±5% threshold
Analyst PT consensus: $599.70 (+27.20%)
Candlestick · 1Y
Open in chart workstation →TMO
469.34+15.86%H 643.99L 385.46MA50 479.37MA200 526.34Avg vol 2.3M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.46% | -4.14% | +7.56% | +1.53% | -18.13% | -18.63% | +16.39% | -11.89% | +0.30% | +219.84% | +37319.05% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$1.58M
10 txns
Net flow
−$1.58M
Aftermarket
LiveLast trade
$471.48
471 sh
Bid
$471.34
1 sh
Ask
$471.62
113 sh
Spread
$0.280
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $11.01B | $1.65B | $4.43 |
| Q4 Dec 2025 | $12.22B | $1.98B | $5.21 |
| Q3 Sep 2025 | $11.12B | $1.62B | $4.27 |
| Q2 Jun 2025 | $10.86B | $1.62B | $4.28 |
| Q1 Mar 2025 | $10.36B | $1.51B | $3.98 |
| Q4 Dec 2024 | $11.4B | $1.83B | $4.78 |
Sector & industry today
LiveSectors
- Financial Services+1.42%
- Utilities+0.91%
- Energy+0.70%
- Industrials+0.26%
- Technology+0.18%
- Communication Services+0.17%
- Consumer Defensive+0.15%
- Real Estate-0.49%
- Healthcare-0.50%
- Consumer Cyclical-0.50%
- Basic Materials-0.82%
Top industries (issuer's industry highlighted)
- Medical - Diagnostics & Research+0.72%
- Department Stores-5.35%
- Oil & Gas Energy+4.44%
- Electronic Gaming & Multimedia+3.70%
- Trucking-3.23%
- Copper-3.12%
- Medical - Equipment & Services+3.07%
- Luxury Goods+3.06%
- Software - Infrastructure+2.91%
- Steel-2.75%
- Regulated Water+2.54%
- Communication Equipment-2.42%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$599.70
+27.20% upside
Low
$490.00
Median
$617.50
High
$683.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- Nalgene Outdoor Introduces Fresh Flow™ Straw Bottlebusinesswire.com·May 11, 2026
- Thermo Fisher Scientific's Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trialsbusinesswire.com·May 06, 2026
- International Markets and Thermo Fisher (TMO): A Deep Dive for Investorszacks.com·May 04, 2026
- Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturingbusinesswire.com·May 04, 2026
- Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturingbusinesswire.com·May 04, 2026
Recent analyst activity
DB- Jun 11, 2026GradeNeutralThermo Fisher initiated with a Neutral at Piper SandlerPiper Sandler
- Jun 11, 2026PT$510.00Thermo Fisher initiated with a Neutral at Piper SandlerPiper Sandler
- Jun 03, 2026GradeBuy → HoldThermo Fisher downgraded to Hold from Buy at HSBCHSBC
- Jun 03, 2026PT$540.00HSBC Downgrades Thermo Fisher Scientific (TMO) to HoldHSBC
Peers
Total assets
$110.34B
Total debt
$40.86B
Cash & equiv
$9.86B
Operating CF
$7.82B
Free cash flow
$6.29B
Buybacks
-$3B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Pettiti Gianluca officer: President & COO | Sell | 400 | $185.06K | Apr 27, 2026 |
Shafer Michael D officer: Executive Vice President | Sell | 1,607 | $802.54K | Mar 11, 2026 |
CASPER MARC N director, officer: Chairman & CEO | Sell | 348 | $179.44K | Mar 05, 2026 |
CASPER MARC N director, officer: Chairman & CEO | Sell | 201 | $103.86K | Mar 05, 2026 |
CASPER MARC N director, officer: Chairman & CEO | Sell | 20 | $10.07K | Mar 05, 2026 |
CASPER MARC N director, officer: Chairman & CEO | Sell | 264 | $137.21K | Mar 05, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $44.56B | $8.11B | $6.74B | $17.74 | +15.12% |
| FY 2024 | $42.88B | $7.66B | $6.34B | $16.53 | +14.77% |
| FY 2023 | $42.86B | $7.45B | $6B | $15.45 | +13.99% |
| FY 2022 | $44.92B | $8.53B | $6.95B | $17.64 | +15.47% |
| FY 2021 | $39.21B | $10.32B | $7.73B | $19.46 | +19.70% |